KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Esperion Therapeutics (ESPR) Times Interest Earned (2019 - 2025)

Esperion Therapeutics' Times Interest Earned history spans 7 years, with the latest figure at $3.77 for Q4 2025.

  • For Q4 2025, Times Interest Earned rose 2200.52% year-over-year to $3.77; the TTM value through Dec 2025 reached $0.71, down 11.62%, while the annual FY2025 figure was $0.71, 22.41% down from the prior year.
  • Times Interest Earned reached $3.77 in Q4 2025 per ESPR's latest filing, up from -$0.45 in the prior quarter.
  • In the past five years, Times Interest Earned ranged from a high of $5.15 in Q1 2024 to a low of -$10.19 in Q1 2021.
  • Average Times Interest Earned over 5 years is -$1.9, with a median of -$2.68 recorded in 2023.
  • The largest YoY upside for Times Interest Earned was 2200.52% in 2025 against a maximum downside of 122.07% in 2025.
  • A 5-year view of Times Interest Earned shows it stood at -$4.14 in 2021, then increased by 28.37% to -$2.97 in 2022, then grew by 5.16% to -$2.81 in 2023, then surged by 93.63% to -$0.18 in 2024, then soared by 2200.52% to $3.77 in 2025.
  • Per Business Quant, the three most recent readings for ESPR's Times Interest Earned are $3.77 (Q4 2025), -$0.45 (Q3 2025), and $0.35 (Q2 2025).